(Stroke. 1995;26:2053-2060.)
© 1995 American Heart Association, Inc.
Articles |
From the Second Department of Internal Medicine and the Department of Radiology (Y.K.), Faculty of Medicine, Kyushu University, Japan.
| Abstract |
|---|
|
|
|---|
Methods We determined blood flow velocity with TCD in the middle cerebral artery and cerebrovascular vasodilator responses to carbon dioxide in 22 patients with or without carotid artery occlusive disease and minor stroke; we compared the results with the measurements of cerebral blood flow and oxygen metabolism by positron emission tomography (PET).
Results Blood flow velocity measured by TCD correlated with ipsilateral cerebral blood flow measured by PET in frontal, temporal, and striatal regions and throughout the entire hemisphere (P<.05 to P<.005). Relative changes in blood flow velocity and calculated cerebrovascular resistance tested by carbon dioxide inhalation both correlated closely with regional mean transit time (calculated as the ratio of cerebral blood volume divided by cerebral blood flow) in frontal, striatal, temporal, parietal, and occipital regions and also in the entire hemisphere (P<.05 to P<.0001). TCD variables did not correlate with hemispheric measurements of oxygen metabolism by PET.
Conclusions Although TCD is not useful in assessing impairments of cerebral metabolism, it is useful for detecting abnormalities of cerebral hemodynamics among patients with risk factors for cerebrovascular disease.
Key Words: blood flow velocity positron emission tomography transcranial Doppler vasomotor reactivity risk factors
| Introduction |
|---|
|
|
|---|
TCD, introduced by Aaslid et al,9 has been used for noninvasive evaluations of cerebral hemodynamics. Dahl et al10 11 12 reported that changes in blood flow velocity measured by TCD correlate well with changes in cerebral blood flow measured by single-photon emission computed tomography; direct comparisons of TCD measurements with estimates of cerebral perfusion and metabolism are available only in the works by Kuwert et al13 and Sitzer et al.14 PET enables reliable and simultaneous measurement of oxygen metabolism and cerebral perfusion states. However, PET is expensive and not generally available. We designed the present study to determine whether cerebral hemodynamics measured by TCD correlate with PET measurements among patients with hypertension or diabetes mellitus and whether TCD measurements correlate with PET measurements of oxygen metabolism.
| Subjects and Methods |
|---|
|
|
|---|
70%, n=4); and group 4, bilateral
hemodynamically significant stenosis (n=5).
Clinical, radiological, and vascular findings are shown in Tables 1
|
|
Regarding vascular risk factors, 14 of 22 patients had hypertension, 3 had diabetes mellitus, and 5 had both. None had severe anemia (hemoglobin, 10.8 to 16.0 g/dL; hematocrit, 35.2 to 48.6%; respectively). Symptomatic but not disabling small strokes were present in 7 patients (patients 8, 9, 11, 14, 15, 18, and 19). Old ischemic lesions, including white matter hyperintensities on T2-weighted MRI, were detected in 19 patients with no hemorrhagic lesions detected. Mild to moderate vascular dementia diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R15 ) was present in 4 patients (Mini-Mental State Examination, 8 to 25 points).
Informed consent was obtained from all patients before they entered the study. In patients with small strokes, cerebral hemodynamics were evaluated at least 1 month after the last stroke.
TCD Study
Resting
TCD examinations were performed within 1 month before PET
studies using methods previously described.16 After the
patient rested for 5 minutes in a supine position, a map of the circle
of Willis and additional major intracranial arteries was generated by
transtemporal TCD mapping with 2-MHz Trans-scan (EME Co
Ltd). Sample volumes were fixed at 6 mm in diameter. Maps and sonograms
were stored for later analysis on hard IBM-PC compatible disks
included in the Trans-scan system. MCAs were insonated at a depth
of 45 to 60 mm.
Response to Carbon Dioxide
A TCD probe was fixed on the temporal bone above the zygomatic
arch with a probe holder (IMP-2, EME). Blood flow signals of the MCA
were insonated and monitored. PECO2 was also
monitored using Normocap 200 (Datex Co Ltd), and blood pressures were
recorded every minute by a measuring device (BP-203I, Nippon Colin
Co Ltd). After a stable state was reached, we recorded MCA
waveforms of 15 cardiac cycles. Using a face mask, patients inhaled a
mixture of 5% CO2 and 95% air for 2 minutes. Blood
pressure, PECO2, and another 15 cardiac
cycles of blood flow velocity were then recorded.
Calculation of Variables
We calculated the time-averaged MFV from five to seven
consecutive heart beats. VMR was defined as relative changes in MFV
divided by the difference in PECO2
(
PECO2) before versus after inhalation
of CO2: VMR=(post-CO2 MFV-resting
MFV)x100/resting MFV/
PECO2.
Slight but significant increases in blood pressure were observed in
some patients after they inhaled CO2 and air. We determined
percentage of change in CVRI as follows: CVRI=MABP/MFV16
and %
CVRI=(resting CVRIpost-CO2 CVRI)x100/resting
CVRI/
PECO2. We used these
parameters for the MCA on the side presumed to have the
more severe impairment of cerebral hemodynamics.
Lateralization of the lesions was judged by clinical profile, MRI and
MRA, or angiography.
PET Measurements
For PET studies, we used a HeadtomeIII device (Shimadzu Inc)
with spatial resolutions of 8.2 mm. As described
previously,17 rCBF, rOEF, and
rCMRO2 were measured by the 15O
steady-state technique. rCBV was determined by single inhalations
of 15O-labeled carbon monoxide gas. rMTTs were calculated
as rCBV/rCBF and were considered reliable indicators of cerebral
perfusion pressure. Regions of interest were determined in frontal,
temporal, parietal, and occipital regions; striatum; and white matter
(Fig 1
). All values on the orbitomeatal
plane plus 50 mm were averaged and used as values for entire
hemispheres. PET studies were conducted blinded, without knowledge of
TCD results.
|
Statistics
Differences in TCD and PET variables between groups were
assessed by ANOVA followed by Scheffé's F test. Correlations
between variables with TCD and PET were assessed by simple
regression analysis. Statistical significance was assumed at a
value of P<.05.
| Results |
|---|
|
|
|---|
|
Regarding CO2 reactivity, impaired VMR (<2%/mm Hg) was found in 3 of 7 patients in group 1, in 2 of 6 patients in group 2, in 2 of 4 patients in group 3, and in 4 of 5 patients in group 4. Mean VMR values or relative changes in CVRI did not differ among groups.
PET Results
PET revealed wide ranges of hemodynamic and
metabolic states, but no differences in PET measurements
were found among the four groups (Table 3
). Positive
correlations between rMTT and rOEF were seen in temporal, parietal, and
striatal regions and for entire hemisphere (r=.44,
r=.60, r=.54, and r=.53, respectively
[P<.05 to P<.005]). rMTT negatively
correlated with rCMRO2 in parietal, striatal, and white
matter regions (r=.42, r=.52, and
r=.70, respectively [P<.05 to
P<.0005]).
Comparison of TCD and PET
Since TCD or PET measurements did not differ significantly among
groups 1 through 4, analyses were performed by combining all
four groups. Relationships between TCD and PET measurements are shown
in Table 4
. MFV correlated with rCBF by PET for entire
hemisphere (P<.05), frontal region (P<.01), and
in the territory of the MCA of temporal and striatal regions
(P<.05; Fig 2
). In temporal and striatal
regions and for entire hemisphere, MFV also correlated with rMTT
(P<.05). MFV also correlated with rOEF in frontal and
striatal regions.
|
|
VMR demonstrated good correlation with rMTT in territorial areas of the
anterior, middle, and posterior cerebral arteries (P<.05 to
P<.0005; Fig 3
). Relative changes in CVRI
also correlated well with rMTT in each region of gray matter
(P<.02 to P<.0001; Fig 4
).
|
|
For entire hemisphere, VMR and relative changes in CVRI correlated with
rMTT (Fig 5A
and 5B
). Relationships
between VMR and oxygen metabolism for entire hemisphere are
shown in Fig 5C
and 5E
. As VMR decreased, rOEF
subsequently increased and rCMRO2 declined. These trends
achieved significance only in frontal region. Relative changes in CVRI
did not correlate with rOEF or rCMRO2 for entire hemisphere
(Fig 5D
and 5F
) or other regions.
|
| Discussion |
|---|
|
|
|---|
MFV and rCBF
MFV by TCD slightly but significantly correlated with rCBF
measured by PET in some carotid arterial territorial
regions and also throughout the entire hemisphere. Bishop et
al19 also demonstrated weak but statistically significant
correlations between blood flow velocity by TCD and CBF measured
by 133Xe among patients with or without carotid
occlusion.
Van der Zwan et al20 demonstrated that territorial distributions of human basal cerebral arteries correlate with vascular diameters. Thus, the diameter of the MCA trunk and the size of the area perfused by the MCA may be assumed to correlate. MFV should have applications for estimating rCBF in a standardized area, since relationships between rCBF and MFV can be expressed as follows: rCBFSTDxPAMCA=MFVxLAMCA, where rCBFSTD indicates rCBF in a standardized area; PAMCA, perfusion area of the MCA; and LAMCA, luminal area of the MCA trunk. These assumptions, however, can only be reasonably applied to patients without significant stenosis or a collateral circulation, such as in groups 1 or 2.
VMR or CVRI Changes Versus Perfusion State
Patients in our study had differing degrees of cerebral
atherosclerosis or arteriolosclerosis. Heistad et
al21 demonstrated that responsiveness of the cerebral
arteries to CO2 is impaired in monkeys with extracranial
atherosclerosis. Clinically, MCA responses to
vasodilatory stimuli are reduced among patients with severe carotid
occlusive disease.22 23 24 25 26 27 28 Some patients with severe carotid
atherosclerosis show compromised intracranial
hemodynamics as measured by PET.29 Maeda
and associates30 reported that CO2 reactivity
was reduced among patients with lacunar infarctions, ie, by
intracranial arteriolopathy. Similarly, Meguro et al31
showed reductions in CBF and CBF-CBV ratios in patients with severe
periventricular hyperintensities by MRI, presumably
indicating arteriolopathy.
Regarding relationships between cerebral vasodilatory responses and perfusions, Herold et al32 compared PET parameters with CO2 reactivity measured by intravenous 133Xe techniques among patients with carotid artery occlusive disease and found significantly linear relationships between CBF-CBV ratio and CO2 reactivity. Hirano et al33 also found that vasomotor reactivity to acetazolamide correlated with the CBF-CBV ratios. Our results indicate that decreases in perfusion pressure due to atherosclerosis or arteriolosclerosis are compensated by vasodilatory reserves. Thus, VMR and relative change in CVRI become reduced in states of compromised cerebral hemodynamics.
CO2 response of the MCA correlated with rMTT in the anterior and posterior cerebral arterial territories; this is probably because the MCA influences maintenance of blood flow to other territories, through bone and degrees of arteriosclerosis (and also vasodilatory response) may not differ significantly within territories of the MCA and anterior and posterior arteries in patients without embolic strokes.
Changes in VMR or CVRI and Metabolism
We failed to show the expected contributions of decreased
CO2 responses to the presence of elevated rOEF and
decreased rCMRO2, as reported
previously.32 33 34 35 In addition to the small sample size of
this study, the following causes would explain the results.
Although 1 patient with extracranial-intracranial bypass
surgery was excluded from the present study and all brain lesions
present in our patients were in chronic stages, PET revealed
heterogeneous relationships between
hemodynamics and metabolic states. The
"misery perfusion pattern" (a decreased rCBF with an increased
rOEF greater than 48%) was seen in only 2 patients (Table 3
; patients
16 and 18), and 6 patients demonstrated the "matched
hypoperfusion"; rCMRO2 was 1.8 mL/100 mL per minute or
less, and rOEF was below 48% (patients 4, 14, 15, 19, 21, and 22).
Metabolic conditions of the brain are altered according to
the severity and stages of ischemia.36 For
example, in patients with unilateral carotid artery occlusive disease,
asymptomatic patients do not show an increase in OEF,
suggesting efficient compensatory mechanism of
hemodynamics,13 whereas
symptomatic patients (ie, those with advanced stages of
occlusive disease) tend to have exhausted vasodilatory capacity and
elevated OEF.36 Thus, it seems likely that the
ischemic brain lesions were in different stages, even in the
same group.
We included 8 diabetic patients (patients 1, 8, 10, 12, 16, 18, 19, and 22). Diabetes mellitus is known to decrease vasodilatory responses37 38 and is involved in progression of arteriolosclerosis and atherosclerosis.39 Grill et al40 observed that global cerebral productions of lactate and pyruvate are higher in diabetic than nondiabetic subjects, and they proposed that a larger fraction of glucose is anaerobically metabolized in diabetic patients. Diabetes mellitus, therefore, influences both vasodilatory responses and cerebral metabolism of glucose and oxygen.
The perfusional states and the oxidative metabolic conditions appear not to be correlated in a simple manner among patients with different stages of brain ischemia, particularly among diabetic patients.
Conclusions
TCD is a reliable method to evaluate decreases in the cerebral
circulation in patients with hypertension or diabetes mellitus. TCD
promises to be useful for the management of such patients when used in
combination with noninvasive morphological imaging such as MR
arteriography and carotid duplex examinations.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
Received May 15, 1995; revision received July 20, 1995; accepted July 27, 1995.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. J. Bos, P. J. Koudstaal, A. Hofman, J. C.M. Witteman, and M. M.B. Breteler Transcranial Doppler Hemodynamic Parameters and Risk of Stroke: The Rotterdam Study Stroke, September 1, 2007; 38(9): 2453 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kadoi, H. Hinohara, F. Kunimoto, S. Saito, M. Ide, H. Hiraoka, F. Kawahara, and F. Goto Diabetic Patients Have an Impaired Cerebral Vasodilatory Response to Hypercapnia Under Propofol Anesthesia Stroke, October 1, 2003; 34(10): 2399 - 2403. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Novak, A. Chowdhary, B. Farrar, H. Nagaraja, J. Braun, R. Kanard, P. Novak, and A. Slivka Altered cerebral vasoregulation in hypertension and stroke Neurology, May 27, 2003; 60(10): 1657 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Derdeyn, R. L. Grubb Jr, and W. J. Powers Re: Stages and Thresholds of Hemodynamic Failure Stroke, March 1, 2003; 34(3): 589 - 589. [Full Text] [PDF] |
||||
![]() |
H Tiemeier, S L M Bakker, A Hofman, P J Koudstaal, and M M B Breteler Cerebral haemodynamics and depression in the elderly J. Neurol. Neurosurg. Psychiatry, July 1, 2002; 73(1): 34 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Dulli Subcortical Infarctions, Transcranial Doppler, and Cerebral Vasomotor Reactivity Arch Neurol, April 1, 2001; 58(4): 551 - 552. [Full Text] [PDF] |
||||
![]() |
C. Tantucci, P. Bottini, C. Fiorani, M. L. Dottorini, F. Santeusanio, L. Provinciali, C. A. Sorbini, and G. Casucci Cerebrovascular reactivity and hypercapnic respiratory drive in diabetic autonomic neuropathy J Appl Physiol, March 1, 2001; 90(3): 889 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Markus and M. Cullinane Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion Brain, March 1, 2001; 124(3): 457 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rodriguez, G. Cornel, W. M. Splinter, N. A. Weerasena, and C. W. Reid Cerebral vascular effects of aortovenous cannulations for pediatric cardiopulmonary bypass Ann. Thorac. Surg., April 1, 2000; 69(4): 1229 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Derdeyn, R. L. Grubb Jr., and W. J. Powers Cerebral hemodynamic impairment: Methods of measurement and association with stroke risk Neurology, July 1, 1999; 53(2): 251 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matteis, E. Troisi, B. C. Monaldo, C. Caltagirone, and M. Silvestrini Age and Sex Differences in Cerebral Hemodynamics : A Transcranial Doppler Study Stroke, May 1, 1998; 29(5): 963 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rodriguez, N. Weerasena, G. Cornel, W. M. Splinter, and D. J. Roberts Cerebral effects of aortic clamping during coarctation repair in children: A transcranial Doppler study Eur. J. Cardiothorac. Surg., February 1, 1998; 13(2): 124 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Omae, S. Ibayashi, K. Kusuda, H. Nakamura, H. Yagi, and M. Fujishima Effects of High Atmospheric Pressure and Oxygen on Middle Cerebral Blood Flow Velocity in Humans Measured by Transcranial Doppler Stroke, January 1, 1998; 29(1): 94 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Silvestrini, E. Troisi, M. Matteis, L. M. Cupini, and C. Caltagirone Transcranial Doppler Assessment of Cerebrovascular Reactivity in Symptomatic and Asymptomatic Severe Carotid Stenosis Stroke, November 1, 1996; 27(11): 1970 - 1973. [Abstract] [Full Text] |
||||
![]() |
J. van der Grond, B.C. Eikelboom, and W.P.Th.M. Mali Flow-Related Anaerobic Metabolic Changes in Patients With Severe Stenosis of the Internal Carotid Artery Stroke, November 1, 1996; 27(11): 2026 - 2032. [Abstract] [Full Text] |
||||
![]() |
P. Demolis, Y. R. T. Dinh, and J.-F. Giudicelli Relationships Between Cerebral Regional Blood Flow Velocities and Volumetric Blood Flows and Their Respective Reactivities to Acetazolamide Stroke, October 1, 1996; 27(10): 1835 - 1839. [Abstract] [Full Text] |
||||
![]() |
R. Kodaka, Y. Itagaki, M. Matsumoto, T. Nagai, and S. Okada A Transcranial Doppler Ultrasonography Study of Cerebrovascular CO2 Reactivity in Mitochondrial Encephalomyopathy Stroke, August 1, 1996; 27(8): 1350 - 1353. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||